Indications
IFA
Kidney diseases comprise a broad range of autoimmune and inflammatory conditions in which the detection of specific autoantibodies plays a key role in diagnosis and differentiation. Precise serological analysis supports accurate clinical assessment and disease monitoring.
Our IFA portfolio for nephrology includes both manual and automated immunofluorescence assays for the qualitative and semi-quantitative detection of relevant autoantibodies. These include tests against glomerular basement membrane (anti-GBM) antigens as well as other nephrology-related targets. The assays provide clear, reproducible results and integrate reliably into routine laboratory workflows. They support laboratories in delivering accurate and efficient diagnostic evaluation.